Jabra Enhance Plus vs Lexie B3

The Jabra Enhance Plus is a mid-priced OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This visible-in-ear device ranks #28 of 65 OTC hearing aids tested, placing it in the top 42% of its category. In our testing, the Enhance Plus demonstrated notable strengths in speech clarity and audio streaming. Speech in quiet scored a strong 4.2/5, measuring 1.36 points above the category average. Music streaming performance was equally impressive at 3.8/5, a full 1.88 points above average—making this a solid choice for users who prioritize phone audio streaming. Feedback handling was excellent at 4.7/5. However, the device has a significant weakness: own-voice comfort scored just 0.3/5, falling 2.21 points below the category average. This suggests pronounced occlusion effects that may make the user's own voice sound boomy or unnatural. Speech in noise performance was mixed at 2.1/5—above the category average by 0.62 points, but still limited in absolute terms for challenging listening environments. The Enhance Plus showed meaningful improvement with tuning, jumping from a normalized Initial Score of 3.6/5 to a Tuned Score of 4.2/5. Buyers should note that several competitors in the same price range score higher, including the Sony CRE-E10 at 4.66/5. This device is best suited for users who prioritize music streaming and speech clarity in quieter settings, and who can tolerate own-voice occlusion.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.